270 related articles for article (PubMed ID: 1900240)
1. Cytokine interactions in experimental cutaneous leishmaniasis. Interleukin 4 synergizes with interferon-gamma to activate murine macrophages for killing of Leishmania major amastigotes.
Bogdan C; Stenger S; Röllinghoff M; Solbach W
Eur J Immunol; 1991 Feb; 21(2):327-33. PubMed ID: 1900240
[TBL] [Abstract][Full Text] [Related]
2. Cytokine interactions in experimental cutaneous leishmaniasis. II. Endogenous tumor necrosis factor-alpha production by macrophages is induced by the synergistic action of interferon (IFN)-gamma and interleukin (IL) 4 and accounts for the antiparasitic effect mediated by IFN-gamma and IL 4.
Stenger S; Solbach W; Röllinghoff M; Bogdan C
Eur J Immunol; 1991 Jul; 21(7):1669-75. PubMed ID: 1905642
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-alpha in combination with interferon-gamma, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes.
Bogdan C; Moll H; Solbach W; Röllinghoff M
Eur J Immunol; 1990 May; 20(5):1131-5. PubMed ID: 2113475
[TBL] [Abstract][Full Text] [Related]
4. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha.
Green SJ; Crawford RM; Hockmeyer JT; Meltzer MS; Nacy CA
J Immunol; 1990 Dec; 145(12):4290-7. PubMed ID: 2124240
[TBL] [Abstract][Full Text] [Related]
5. Cytokine interactions in experimental cutaneous leishmaniasis.
Solbach W; Röllinghoff M; Stenger S; Bogdan C
Behring Inst Mitt; 1991 Feb; (88):230-8. PubMed ID: 1904708
[TBL] [Abstract][Full Text] [Related]
6. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
Sadick MD; Locksley RM; Tubbs C; Raff HV
J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
[TBL] [Abstract][Full Text] [Related]
7. Antigen-specific activation of effector macrophages by IFN-gamma producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function in macrophages.
Stout RD; Bottomly K
J Immunol; 1989 Feb; 142(3):760-5. PubMed ID: 2464024
[TBL] [Abstract][Full Text] [Related]
8. IL-6 down-modulates the cytokine-enhanced antileishmanial activity in human macrophages.
Hatzigeorgiou DE; He S; Sobel J; Grabstein KH; Hafner A; Ho JL
J Immunol; 1993 Oct; 151(7):3682-92. PubMed ID: 8397259
[TBL] [Abstract][Full Text] [Related]
9. Phagocytosis enhances murine macrophage activation by interferon-gamma and tumor necrosis factor-alpha.
Corradin SB; Buchmüller-Rouiller Y; Mauël J
Eur J Immunol; 1991 Oct; 21(10):2553-8. PubMed ID: 1915557
[TBL] [Abstract][Full Text] [Related]
10. Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major.
Doherty TM; Coffman RL
J Immunol; 1993 Jun; 150(12):5476-83. PubMed ID: 8515072
[TBL] [Abstract][Full Text] [Related]
11. Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection.
Belosevic M; Davis CE; Meltzer MS; Nacy CA
J Immunol; 1988 Aug; 141(3):890-6. PubMed ID: 3135315
[TBL] [Abstract][Full Text] [Related]
12. Leishmania major: differential resistance to infection in C57BL/6 (high interferon-alpha/beta) and congenic B6.C-H-28c (low interferon-alpha/beta) mice.
Shankar AH; Morin P; Titus RG
Exp Parasitol; 1996 Nov; 84(2):136-43. PubMed ID: 8932763
[TBL] [Abstract][Full Text] [Related]
13. Regulation of activated macrophage antimicrobial activities. Cooperation of lymphokines for induction of resistance to infection.
Davis CE; Belosevic M; Meltzer MS; Nacy CA
J Immunol; 1988 Jul; 141(2):627-35. PubMed ID: 3133412
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide.
Liew FY; Li Y; Millott S
J Immunol; 1990 Dec; 145(12):4306-10. PubMed ID: 2175327
[TBL] [Abstract][Full Text] [Related]
15. IL-2 is necessary for the progression of leishmaniasis in susceptible murine hosts.
Heinzel FP; Rerko RM; Hatam F; Locksley RM
J Immunol; 1993 May; 150(9):3924-31. PubMed ID: 8473741
[TBL] [Abstract][Full Text] [Related]
16. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.
Scott P
J Immunol; 1991 Nov; 147(9):3149-55. PubMed ID: 1833466
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation.
Vouldoukis I; Bécherel PA; Riveros-Moreno V; Arock M; da Silva O; Debré P; Mazier D; Mossalayi MD
Eur J Immunol; 1997 Apr; 27(4):860-5. PubMed ID: 9130636
[TBL] [Abstract][Full Text] [Related]
18. Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL)3 and IL4 produced by disease-promoting T cells in leishmaniasis.
Liew FY; Millott S; Li Y; Lelchuk R; Chan WL; Ziltener H
Eur J Immunol; 1989 Jul; 19(7):1227-32. PubMed ID: 2503386
[TBL] [Abstract][Full Text] [Related]
19. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major.
Belosevic M; Finbloom DS; Van Der Meide PH; Slayter MV; Nacy CA
J Immunol; 1989 Jul; 143(1):266-74. PubMed ID: 2499629
[TBL] [Abstract][Full Text] [Related]
20. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
